COMPASS Pathways plc

CMPS41

$5.04arrow_drop_up3.06%$0.15

CMPS41

$5.04

arrow_drop_up3.06%$0.15

Performance History

Key Stats
Open	$5.02
Prev. Close	$4.98
EPS	-2.15
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$334.57M
PE Ratio	-

	LOW	HIGH
Day Range	4.80	5.17
52 Week Range	3.85	12.75

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-2.15

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About COMPASS Pathways plc (CMPS)

COMPASS Pathways plc (CMPS) is a company focused on accelerating the development of evidence-based innovation medicines to treat mental health disorders. The company is dedicated to improving the lives of patients who suffer from treatment-resistant depression (TRD), a debilitating condition that affects millions of people worldwide. CMPS is pioneering a breakthrough therapy called psilocybin therapy, which utilizes a psychoactive compound found in psychedelic mushrooms to effectively treat TRD. This innovative approach has shown promising results in clinical trials, demonstrating significant reductions in depressive symptoms and improved overall well-being.

CMPS stock has experienced significant fluctuations in its price history, reflecting the volatile nature of the biotech industry. However, the company's groundbreaking research and potential to revolutionize the field of mental health treatment have attracted the attention of investors and analysts alike. As a result, CMPS stock has seen substantial growth in recent months, reaching an all-time high. This surge in stock price can be attributed to positive news surrounding the company's clinical trials and regulatory approvals, which have instilled confidence in investors.

Websitecall_made

Sector: Healthcare
Industry: Medical Care Facilities
CEO: Mr. Kabir Nath M.A., M.B.A.
Headquarters: London
Employees: 181
Exchange: NASDAQ

Keep an eye on COMPASS Pathways plc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is COMPASS Pathways plc's (CMPS) price per share?

The current price per share for COMPASS Pathways plc (CMPS) is $5.04. The stock has seen a price change of $0.15 recently, indicating a 3.07% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for COMPASS Pathways plc (CMPS)?

For COMPASS Pathways plc (CMPS), the 52-week high is $12.75, which is 152.98% from the current price. The 52-week low is $3.85, the current price is 30.74% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is COMPASS Pathways plc (CMPS) a growth stock?

COMPASS Pathways plc (CMPS) has shown an average price growth of -4.94% over the past three years. It has received a score of 6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying COMPASS Pathways plc as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is COMPASS Pathways plc (CMPS) stock price performance year to date (YTD)?

As of the latest data, COMPASS Pathways plc (CMPS) has a year-to-date price change of -43.94%. Over the past month, the stock has experienced a price change of -17.65%. Over the last three months, the change has been -26.64%. Over the past six months, the figure is -38.31%.

help

Is COMPASS Pathways plc (CMPS) a profitable company?

COMPASS Pathways plc (CMPS) has a net income of -$118.92M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$136.92M. Furthermore, the EBITDA is -$153.87M.

help

What is the market capitalization of COMPASS Pathways plc (CMPS)?

COMPASS Pathways plc (CMPS) has a market capitalization of $344.84M. The average daily trading volume is 5.44, indicating the stock's liquidity and investor engagement.